These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31382411)

  • 1. DNA-Methylation-Caused Downregulation of
    Azmi AS; Li Y; Aboukameel A; Muqbil I; Philip PA; Mohammad RM
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31382411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration.
    Azmi AS; Li Y; Muqbil I; Aboukameel A; Senapedis W; Baloglu E; Landesman Y; Shacham S; Kauffman MG; Philip PA; Mohammad RM
    Oncotarget; 2017 Oct; 8(47):82144-82155. PubMed ID: 29137251
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Birnbaum DJ; Finetti P; Birnbaum D; Mamessier E; Bertucci F
    J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31052304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
    Subhash VV; Yeo MS; Wang L; Tan SH; Wong FY; Thuya WL; Tan WL; Peethala PC; Soe MY; Tan DSP; Padmanabhan N; Baloglu E; Shacham S; Tan P; Koeffler HP; Yong WP
    Sci Rep; 2018 Aug; 8(1):12248. PubMed ID: 30115935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
    Tabe Y; Kojima K; Yamamoto S; Sekihara K; Matsushita H; Davis RE; Wang Z; Ma W; Ishizawa J; Kazuno S; Kauffman M; Shacham S; Fujimura T; Ueno T; Miida T; Andreeff M
    PLoS One; 2015; 10(9):e0137210. PubMed ID: 26340096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression.
    Aboukameel A; Muqbil I; Baloglu E; Senapedis W; Landesman Y; Argueta C; Kauffman M; Chang H; Kashyap T; Shacham S; Neggers JE; Daelemans D; Heath EI; Azmi AS
    Oncotarget; 2018 Oct; 9(82):35327-35342. PubMed ID: 30450161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.
    Sexton R; Mahdi Z; Chaudhury R; Beydoun R; Aboukameel A; Khan HY; Baloglu E; Senapedis W; Landesman Y; Tesfaye A; Kim S; Philip PA; Azmi AS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Export Inhibition for Pancreatic Cancer Therapy.
    Muqbil I; Azmi AS; Mohammad RM
    Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29735942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
    Chen Y; Camacho SC; Silvers TR; Razak AR; Gabrail NY; Gerecitano JF; Kalir E; Pereira E; Evans BR; Ramus SJ; Huang F; Priedigkeit N; Rodriguez E; Donovan M; Khan F; Kalir T; Sebra R; Uzilov A; Chen R; Sinha R; Halpert R; Billaud JN; Shacham S; McCauley D; Landesman Y; Rashal T; Kauffman M; Mirza MR; Mau-Sørensen M; Dottino P; Martignetti JA
    Clin Cancer Res; 2017 Mar; 23(6):1552-1563. PubMed ID: 27649553
    [No Abstract]   [Full Text] [Related]  

  • 13. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells.
    Gruffaz M; Yuan H; Meng W; Liu H; Bae S; Kim JS; Lu C; Huang Y; Gao SJ
    mBio; 2019 May; 10(3):. PubMed ID: 31088931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
    Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
    Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
    Yi JM; Kang EJ; Kwon HM; Bae JH; Kang K; Ahuja N; Yang K
    Oncotarget; 2017 Apr; 8(16):26600-26612. PubMed ID: 28460450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.
    Xu RL; He W; Tang J; Guo W; Zhuang P; Wang CQ; Fu WM; Zhang JF
    Exp Cell Res; 2018 Feb; 363(2):310-314. PubMed ID: 29366808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
    Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
    Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.